HealthQuill Blog Health
Novo Nordisk, a Danish drugmaker, announced its weight-loss medicine, Wegovy, will be available in the UK in a “controlled and limited” manner.
Drugs Health Pharma

EMA expands inquiry into suicidal thoughts linked to GLP-1 weight loss drugs

HQ Team December 2, 2023: The European Medicines Agency (EMA) is intensifying its investigation into the potential link between certain GLP-1 receptor agonist.

Read More
A clutch of 41 multilateral development banks, funders, countries and philanthropies announced a global funding plan to cut greenhouse gas emissions and to protect people from climate risks to health.
Climate Health Pharma

COP28: Funding pathway to cut emissions, protect people from risks

HQ Team November 2, 2023: A clutch of 41 multilateral development banks, funders, countries and philanthropies announced a global funding plan to cut.

Read More
Pfizer Inc., has discontinued its clinical trials of the twice-daily oral weight-loss drug, danuglipron, after more than 50% of the patients opted out due to adverse effects of the medicine.
Drugs Health Pharma

Pfizer Inc., stops twice-daily oral obesity drug trial at mid-stage

HQ Team December 2, 2023: Pfizer Inc., has discontinued its clinical trials of the twice-daily oral weight-loss drug, danuglipron, after more than 50%.

Read More
The US Food and Drug Administration (USFDA) is assessing the potential for failures in plastic syringes manufactured in China.
Drugs Health Pharma

FDA probes failure of syringes made in China for possible breakages

HQ Team December 1, 2023: The US Food and Drug Administration (USFDA) is assessing the potential for failures in plastic syringes manufactured in.

Read More
The full year 2023 is set to be the warmest on record with global temperatures rising 1.4 degrees Celsius above pre-industrial levels, as the UN chief called on COP28 nations to set “clear expectations” for climate goals and invest in their implementation. Image Credit: UN
Climate Health Pharma

Record global heat ‘sending shivers down the spines of world leaders’: UN

HQ Team December 1, 2023: The full year 2023 is set to be the warmest on record with global temperatures rising 1.4 degrees.

Read More
AbbVie Inc., operating in therapeutic areas such as immunology, oncology, neuroscience, and eye care, announced a pact to acquire ImmunoGen, Inc., for $10.1 billion. Image Credit: AbbVie
Drugs Health Pharma

AbbVie to buy Immunogen for $10.1b to expand solid tumour market

HQ Team November 30, 2023: AbbVie Inc., operating in therapeutic areas such as immunology, oncology, neuroscience, and eye care, announced a pact to.

Read More
Exposure to typical levels of traffic-related air pollution can diminish brain function within hours, according to researchers at the University of British Columbia.
Climate Health Medical

Commute-linked air pollution has alarming Impact on blood pressure

HQ Team November 30, 2023: Rush hour traffic is an everyday reality for most city dwellers. Adding to the frustration of being stuck.

Read More
The COP28 has reached an agreement to operationalise a fund, known as ‘loss and damage’ to aid developing nations to mitigate the adverse effects of climate change.
Climate Health Pharma

‘Loss and damage’ climate mitigation fund gets going at COP28

HQ Team November 30, 2023: The COP28 has reached an agreement to operationalise a fund, known as ‘loss and damage’ to aid developing.

Read More
Drugs Health Medical

Exercise, a promising approach to tackle postpartum depression

HQ Team November 30, 2023: Postpartum depression is a common psychological affliction following childbirth and affects 17.22% of the world population. Postpartum depression.

Read More
The move to serve Indian millet-based food, to G20 leaders in New Delhi in September 2023 was received with surprise by many. Compared to cereals like rice and wheat, millets were not given much significance and now they are considered as super food with high nutritive value.
Drugs Health Pharma

Opinion: Feast for G20 leaders, benefits of millets exceed rice, wheat

By Dr. K. Leelamoni November 30, 2023: The move to serve Indian millet-based food, to G20 leaders in New Delhi in September 2023.

Read More
X